Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Inspire Medical Systems (INSP) Gross Profit (2017 - 2025)

Inspire Medical Systems (INSP) has disclosed Gross Profit for 9 consecutive years, with $233.0 million as the latest value for Q4 2025.

  • Quarterly Gross Profit rose 14.37% to $233.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $778.8 million through Dec 2025, up 14.55% year-over-year, with the annual reading at $778.8 million for FY2025, 14.55% up from the prior year.
  • Gross Profit hit $233.0 million in Q4 2025 for Inspire Medical Systems, up from $192.7 million in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $233.0 million in Q4 2025 to a low of $34.4 million in Q1 2021.
  • Historically, Gross Profit has averaged $126.4 million across 5 years, with a median of $127.9 million in 2023.
  • Biggest five-year swings in Gross Profit: surged 344.24% in 2021 and later increased 9.86% in 2025.
  • Year by year, Gross Profit stood at $67.2 million in 2021, then soared by 72.14% to $115.7 million in 2022, then soared by 42.08% to $164.5 million in 2023, then grew by 23.88% to $203.7 million in 2024, then rose by 14.37% to $233.0 million in 2025.
  • Business Quant data shows Gross Profit for INSP at $233.0 million in Q4 2025, $192.7 million in Q3 2025, and $182.4 million in Q2 2025.